Uriach acquires two new companies in Italy
The pharmaceutical company Uriach has completed the acquisition of two Italian companies specialising in innovative food supplements that are marketed in visits to health professionals.
The pharmaceutical company Uriach has completed the acquisition of two Italian companies specialising in innovative food supplements that are marketed in visits to health professionals.
The pharmaceutical company Uriach has completed its strategic plan 2013‑2017 with record revenue of one hundred and seventy-four million euros, 75% more than in 2012 (the year before the start of the strategic plan 2013-17). The company’s gross operating profit (ebitda) also increased significantly from €12 million in 2012 to €51 million last year. Uriach thus outperformed the targets set for the strategic plan (€170 mn revenue and €50 mn ebitda).